News NVIDIA sinks $2bn into AI cloud provider Nebius NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius to ramp up infrastructure as demand soars in the life sciences.
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
